PSMG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.797800E-01
Normal-vs-Stage2
9.848200E-01
Normal-vs-Stage3
9.505800E-01
Normal-vs-Stage4
3.404600E-01
Stage1-vs-Stage2
9.944400E-01
Stage1-vs-Stage3
9.481200E-01
Stage1-vs-Stage4
3.717800E-01
Stage2-vs-Stage3
9.203000E-01
Stage2-vs-Stage4
4.189800E-01
Stage3-vs-Stage4
6.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.826800E-01
Normal-vs-AfricanAmerican
7.526600E-01
Normal-vs-Asian
7.605200E-01
Caucasian-vs-AfricanAmerican
5.572200E-01
Caucasian-vs-Asian
5.579400E-01
AfricanAmerican-vs-Asian
8.968600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.606200E-01
Normal-vs-Female
9.310200E-01
Male-vs-Female
6.005000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.949800E-01
Normal-vs-Age(41-60Yrs)
8.114000E-01
Normal-vs-Age(61-80Yrs)
8.977400E-01
Normal-vs-Age(81-100Yrs)
5.293800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.974830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.544600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.365420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.231600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.813800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.643590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.028600E-01
Normal-vs-Daily Drinker
6.165200E-01
Normal-vs-Weekly Drinker
5.507200E-01
Normal-vs-Occasional Drinker
8.849800E-01
Normal-vs-Social Drinker
9.038200E-01
Non Drinker-vs-Daily Drinker
5.052600E-01
Non Drinker-vs-Weekly Drinker
1.525560E-01
Non Drinker-vs-Occasional Drinker
6.132400E-01
Non Drinker-vs-Social Drinker
6.716400E-01
Daily Drinker-vs-Weekly Drinker
4.783900E-02
Daily Drinker-vs-Occasional Drinker
2.143200E-01
Daily Drinker-vs-Social Drinker
2.443600E-01
Weekly Drinker-vs-Occasional Drinker
2.944000E-01
Weekly Drinker-vs-Social Drinker
2.954600E-01
Occasional Drinker-vs-Social Drinker
9.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.059600E-01
Normal-vs-Grade 2
8.808200E-01
Normal-vs-Grade 3
8.739200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.442300E-02
Grade 1-vs-Grade 3
1.356360E-01
Grade 1-vs-Grade 4
8.059600E-01
Grade 2-vs-Grade 3
8.508200E-01
Grade 2-vs-Grade 4
8.808200E-01
Grade 3-vs-Grade 4
8.739200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.098400E-01
Normal-vs-NonDiabetic
9.582200E-01
Diabetic-vs-NonDiabetic
2.985200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.538800E-01
Normal-vs-NoPancreatitis
9.554000E-01
Pancreatitis-vs-NoPancreatitis
2.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.657000E-01
Normal-vs-N1
9.257000E-01
N0-vs-N1
1.765590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.054600E-01
Normal-vs-TP53-NonMutant
8.204800E-01
TP53-Mutant-vs-TP53-NonMutant
1.496790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
